Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Ng, GB
Chong Ng, Tyne And Wear GB
| Patent application number | Description | Published |
|---|---|---|
| 20110304272 | Method, operating device, and lighting system - The application relates to a circuit for operating a light-emitting means, having a half-bridge or full-bridge circuit for providing a supply voltage for the at least one light-emitting means, and a control circuit for the closed-loop control of the operation of the light-emitting means and/or fault identification. A measurement signal which represents the current through the bridge circuit and/or a measurement signal which represents the lamp current and a measurement signal which represents the voltage across the at least one light-emitting means are supplied to the control circuit at the same input. | 12-15-2011 |
Gary Ka Lai Ng, Cheshire GB
| Patent application number | Description | Published |
|---|---|---|
| 20080271733 | Methods of Providing Medicinal Metal Components Having Through Holes - A metal component, in particular a metal component of a medicinal device, such as a pharmaceutical aerosol delivery device, having a through hole extending along an axis from a first surface ( | 11-06-2008 |
Jason W. P. Ng, Suffolk GB
| Patent application number | Description | Published |
|---|---|---|
| 20100325074 | REMOTE MONITORING THRESHOLDS - Apparatus for generating a threshold value indicative of a status change, comprising a trend projection engine for processing a plurality of sensed values in an order of value size to generate a corresponding predicted value for each of the plurality of sensed values, by reference to a value sequence trend of the plurality of sensed values, a comparator for comparing one or more of the plurality of sensed values against their corresponding predicted values to identify an abnormal sensed value which differs from its corresponding predicted value by a pre-specified amount, and a threshold generator for using the abnormal sensed value to identify the threshold value. | 12-23-2010 |
Leong Ng, Leicester GB
| Patent application number | Description | Published |
|---|---|---|
| 20090081714 | Assays - Methods and assays for monitoring the cardiac health of a subject are provided. The method involves the detection of a urotensin surrogate in a sample leading to a more accurate and reliable diagnosis of early or late stages of decompensated heart failure, heart failure, risk of a heart failur in a subject than the measurement of the cyclic peptide of urotensin alone. | 03-26-2009 |
Leong L. Ng, Leicester GB
| Patent application number | Description | Published |
|---|---|---|
| 20100028921 | RISK STRATIFICATION FOR ACUTE CORONARY SYNDROME BY MEANS OF FRAGMENTS/PARTIAL PEPTIDES OF PROVASOPRESSIN, ESPECIALLY COPEPTIN OR NEUROPHYSIN II - The invention relates to a method for risk stratification for acute coronary syndrome (ACS), in particular acute myocardial infarction (AMI) and angina pectoris (AP), wherein provasopressin (proAVP) or fragments and partial peptides thereof, in particular copeptin or neurophysin II, is determined by an in vitro diagnosis. | 02-04-2010 |
| 20100151504 | DIAGNOSIS AND RISK CLASSIFICATION OF ACUTE CORONARY SYNDROME BY MEANS OF CT-PROET-1 IN COMBINATION WITH NT-PROBNP - The invention relates to a method for diagnosis and/or risk classification for acute coronary syndrome (ACS), in particular for acute myocardial infarct (AMI) and angina pectoris (AP) and/or a post-myocardial infarct, wherein a determination of the C-terminal pro-endothelin (CT-proET-1) or fragments and partial peptides therefrom, is carried out in combination with NT-proBNP. | 06-17-2010 |
Leong Loke Ng, Leicester GB
| Patent application number | Description | Published |
|---|---|---|
| 20080213746 | Methods of Diagnosis and Risk Stratification of Adverse Events in Post Myocardial Infarction Patients Using Pro-adrenomedullin - The invention provides methods for the diagnosis and risk stratification of adverse events in post-myocardial infarction patients by means of proADM, whereby a determination of the marker pro-adrenomedullin or partial sequence or a fragment thereof or contained in a marker combination (panel, cluster) is carried out on a post-myocardial infarction patient. The invention also provides a diagnostic device and a kit for the performance of the method of the method of the invention. | 09-04-2008 |
Leong Loke Ng, Leicestershire GB
| Patent application number | Description | Published |
|---|---|---|
| 20110117589 | USE OF PROCALCITONIN (PCT) IN PROGNOSIS FOLLOWING ACUTE CORONARY SYNDROMES - Subject of the present invention are assays and in vitro methods for determining a prognosis for a patient having an acute coronary syndrome, whereby the level of procalcitonin or fragments thereof is measured in a sample obtained from said patient. Said level of procalcitonin or fragments thereof may then be correlated to a predisposition to an adverse outcome of said acute coronary syndrome. | 05-19-2011 |
| 20110229911 | AZUROPHILIC GRANULE PROTEASES AS MARKERS IN CARDIOLOGICAL DISEASES - The present invention is concerned with an assay for detecting and/or determining the level of a protease from azurophilic granules of polymorphonuclear neutrophils or a complex thereof with an endogenous inhibitor for risk stratification and/or prognosis and/or therapy control and/or monitoring of a patient having a cardiological disease or condition. | 09-22-2011 |